2-bromo-1H-imidazo[4,5-b]pyridine, 97%, 5g

N1-Benzyl-N1,N3,N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine, 98%, 5g

2,4-Dihydro-5-[2,4-dihydroxy-5-isopropylphenyl]-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one, 100mg

(S)-3,5-dichloro-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dihydroxybenzamide, 98%, 1g

4-Bromothiazol-2-ol, 95.0%, 250mg

Acetonitrile ROTISOLV®, min. 99.8%, for preparative HPLC, 2.5 l, glass packaging

3-Methoxy-5-methylpyridine, 95+%, 500mg

6-fluoro-1,3-benzoxazol-2(3H)-one, 95.0%, 1g

N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl}-2-methylpropanamide, 97%, 5g

Perfluoro-2,5-dimethyl-3,6-dioxanonanoic acid,methyl ester, 97.0%, 100g

1-Phenylpiperidine-2-carboxylic acid, 95.0%, 100mg

Carvacrol methyl ether, 97%, 5g

Quinoxalin-5-ylmethanamine, 97%, 100mg